Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triazavirin for hospitalized adults with COVID-19
ChiCTR2000030001Phase 3Recruiting
- Sponsor
- Health Commission of Heilongjiang Province
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of favipiravir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Health Commission of Heilongjiang Province. Primary endpoint: Time to clinical recovery. Started Feb 2020; status: recruiting.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000030001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030001.